Torrent Pharmaceuticals

Torrent Pharmaceuticals
Torrent Pharmaceuticals
Shareholder Return: 3-year average, Sales Growth: 3-year Compounded Annual Growth Rate, Return On Equity: 3-year Return on Equity.
At a Glance
  • Shareholder Return
    294%
  • Sales Growth
    20%
  • Return on Equity
    36 %

Why Super 50

The company is a favourite among analysts for its robust track record of execution and strong balance sheet. It has a strong focus on India and the US markets. The company, which raised about Rs 10,000 crore by issuing securities this January, has said it is open to acquisitions to fuel growth.



More Stories

X